Physician profile
John T Batter
NPI 1932189453
$29,202.04
in general payments reported to CMS, 2019-2025
54 companies · $511 in 2025
The $511 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,100 · 2020: $1,784 · 2021: $17K · 2022: $2,718 · 2023: $1,961 · 2024: $2,564 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,259 · Travel and Lodging: $762 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,258.78 |
| Travel and Lodging | $762.48 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,736.02 | 2021-2024 | Da Vinci Surgical System |
| Atricure, INC. | $2,692.16 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $1,475.78 | 2019-2020 | |
| Artivion, INC. | $916.97 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Amds-Ascyrus Medical |
| Edwards Lifesciences Corporation | $817.91 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $650.39 | 2019-2023 | Epic |
| Medtronic, INC. | $550.44 | 2021-2025 | Corevalve Evolut R, Micra, Penditure |
| Boston Scientific Corporation | $224.52 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Baxter Healthcare | $218.22 | 2022-2024 | Preveleak |
| Corcym INC | $182.26 | 2022-2024 | Memo 4d, Miami Instruments |
| Pfizer INC. | $120.78 | 2022-2025 | |
| Angiodynamics, INC. | $119.38 | 2020 | |
| Mallinckrodt Enterprises LLC | $111.61 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.77 | 2019-2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $105.00 | 2019-2025 | Covera |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Batter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.